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and Louis M. Messina, MD,a Worcester, Mass
Objective: Vascular surgeons (VS), interventional cardiologists (IC), and interventional radiologists (IR) perform
peripheral arterial interventions (PAI). In this study, we reviewed market share trends and compared outcomes for each
specialty using the National Inpatient Sample (NIS).
Methods: Patient discharges for PAI (1998-2005) were identified based on ICD9-CM procedure codes. The provider’s
specialty was identified by a specialty-specific algorithm and analyzed using SAS 9.1 (SAS Institute, Cary, NC). Market
share trends and distribution of cases at teaching versus non-teaching hospitals were evaluated. Primary outcome
measures were in-hospital mortality and iatrogenic arterial injuries (IAI). Multivariate logistic regression was performed
to identify independent predictors of post-procedure morbidity and mortality.
Results: The number of cases identified was 23,825. From 1998 to 2005, IR’s market share decreased six-fold (1998: 33%
to 2005: 5.6%) whereas VS market share increased from 27% to 43% and IC from 10% to 29% (P < .05). A similar but
more pronounced trend was observed at teaching hospitals. In-hospital mortality rate was highest for IR (2.1 IR% vs 1.2%
VS and 0.6% IC; P < .001). Post-procedure IAI was highest in the IC group (1.3% vs IR 0.9% and 0.5% VS; P < .05).
Compared with VS, the mortality rate was 1.62 times higher for IR patients (odds ratio [OR]: 1.62, 95% confidence
interval [CI]: 1.16-2.24) and IAI was 2.44 times higher for IC (OR: 2.44, 95% CI: 1.63-3.66) and 1.75 times higher for
IR (OR: 1.75, 95% CI: 1.08-2.81) patients.
Conclusions: IR market share of PAI has precipitously declined while those of VS and IC have increased significantly.
Vascular surgeons had the lowest overall morbidity andmortality of all groups. Increase in the number of endovascularly-
trained VS with better access to fluoroscopy units may further increase VS’s market share. ( J Vasc Surg 2009;50:
1071-8.)Peripheral arterial endovascular procedures were first
described in the late 1960s by Andreas R. Gruntzig, a
German cardiologist.1 His revolutionary work led to the
development of the field of coronary and peripheral vascu-
lar interventions. Currently, transcutaneous coronary re-
vascularizations are performed at high volumes, and often
as the first line of therapy in patients with symptomatic
coronary artery disease. This has led to a significant drop in
the volume of coronary artery bypass operations.2 This
trend is due to significant advances in technology that make
these interventions effective with minimal procedural mor-
bidity. Technical success and market forces advertising
these technologies have led to a general patient population
acceptance of these procedures as “commonplace,” “mi-
nor,” and an “equal” alternative to significantly more mor-
bid open coronary revascularization, despite results to the
contrary.3 A similar trend is sweeping the field of vascular
surgery, where, for example, the rate of endovascular aortic
aneurysm repair procedures (EVAR) is far outpacing that of
open aortic surgery.4,5 Although in the case of EVAR, the
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doi:10.1016/j.jvs.2009.06.013immediate4,6 and mid-term benefits6 of EVAR over open
aortic aneurysm repair have been shown, similar advantages
of peripheral interventions over traditional open surgical
interventions or non-operative therapies have not been
clearly proven.7
Despite a lack of clear consensus about their role,
peripheral arterial interventions have changed the land-
scape for the care of patients with peripheral arterial disease
(PAD). The number of these interventions has increased
seven-fold from 1976 to 1996.8 More recently, Nowygrod
et al described a 40% increase in the volume of in-hospital
endovascular interventions from 1996 to 2003, despite a
stable overall vascular surgical volume.9 Many factors con-
tribute to this increase in the utilization of peripheral
arterial interventions. As these procedures are more com-
monly utilized in the elderly9 and PAD is more prevalent
among the elderly,10 perhaps an important contributing
factor to this increased utilization is the aging US popula-
tion (http://www.census.gov). Also, as PAD often exists in
patients who have coronary artery disease,11 and as700,000
cardiac catheterization procedures are performed yearly in
the US,12 interventional cardiologists (IC) have direct ac-
cess to a large population of patients who also have PAD.
Interventional cardiologists have gone so far as to suggest
that peripheral arterial interventions are a logical extension
of their catheter skills.13 More recently, endovascularly-
trained vascular surgeons (VS) have also been performing
more peripheral interventions to the point that has sug-
gested a burgeoning paradigm shift in the vascular surgery
filed where peripheral interventions are replacing tradi-
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vascular interventions in patients with PAD who were
previously treated almost exclusively by the interventional
radiologist (IR). The purpose of this study was to evaluate
the market shares of these three specialists for peripheral
arterial interventions. We also compare the outcomes
among the three specialties by comparing mortality and
iatrogenic arterial injuries.
METHODS
In order to evaluate surgical outcomes for patients
undergoing lower extremity interventions, we used the
Nationwide Inpatient Sample (NIS) for the calendar years
1998- 2005, the most recent available data as of September
2008. The NIS is the largest database of its kind and
includes all-payer discharge information from a national
survey of 20% of all non-federal hospitals in the US. A
complete overview and description of the NIS is available on
their website, http://www.hcup-us.ahrq.gov/nisoverview.
jsp.
The studied cohort was comprised by linking the Inter-
national Classification of Diseases, Ninth Revision, Clinical
Modification (ICD9-CM) procedure codes for all patient-
discharges for in-hospital peripheral arterial interventions.
All cases with a primary procedure code for peripheral vessel
angioplasty/atherectomy (ICD-9 code 39.50, 39.90)
and/or stent insertion (ICD-9 code 00.55) were identified.
Lower extremity peripheral interventions were then identi-
fied using the inclusion/exclusion criteria detailed in Table
I. Pediatric cases (age 18) were excluded from the study.
As NIS does not provide the specialty, we used an
algorithm to determine the specialty of the provider. This
methodology is similar to a previously published method-
ology.15 Only NIS data that included provider identifiers
were used in this analysis, and we did not employ any
weighting strategies to avoid possible errors in the statistical
Table I. ICD-9 codes
ICD-9 Code Procedure
88.48 Arteriography of femoral and lower extremity
arteries
39.50 Peripheral vessel angioplasty
39.90 Peripheral atherectomy
00.55 Percutaneous insertion of stent
Diagnosis
448.81, 444.22 Thrombosis/embolism of iliac or lower
extremity vessels
443.9 Peripheral vascular disease NOS
250.7 Diabetes with peripheral circulatory
complications
440.2 Atherosclerosis of native vessels
707.1 Ulcer of lower limb
ICD-9, International Classification of Diseases, Ninth Revision; NOS, not
otherwise specified.
Database first queried to identify all patients undergoing peripheral inter-
vention. Initial cohort limited to patients with admitting diagnosis sugges-
tive of peripheral arterial disease. Pediatric patients were excluded.analysis. Additionally, to increase the homogeneity of thestudy samples, we excluded all the states that did not
provide unique provider or hospital identifiers. The practi-
tioner’s specialty was inferred based on the provider per-
forming three “index” procedures per calendar year from
one column in Table II. We found that using three index
procedures provided the clearest designation and, at the
same time, the least overlap among the specialties. Variables
were then created for each operator type and set to 1 if the
operator performed equal to or more than three index
procedures and 0 if otherwise. An operator type was then
created as follows:
0 for any cases that did not match any operations in the
VS/IC/IR databases or had overlapping results (ie,
matched with multiple operator specialties)  other;
1 for all cases that matched solely in the VS group  VS;
2 for all cases that matched solely in the IC group  IC;
3 for all cases that matched solely in the IR group  IR.
Since record sampling in the NIS does not correlate across
years, a continuous single provider identifier was not pos-
sible. Due to the variable for practitioner identifiers chang-
ing twice during the study period, and to concerns regard-
ing the fidelity of the practitioner identifiers from year to
year, all calculations were done on a year-to-year basis and
the relative market share rather than absolute numbers are
reported. For these reasons, we did not comment on the
provider groups’ volume or procedure volume trends.
The primary outcome measures for this retrospective
study were 1) changes inmarket share by operator type over
time, 2) postoperative in-hospital death, and 3) iatrogenic
arterial injury. Iatrogenic arterial injury has a specific
ICD9-CM code (998.02); therefore any patient undergo-
ing peripheral arterial interventions that had this code
under one of their secondary ICD9-CM diagnostic codes
(up to 15) was classified as having an iatrogenic post-
procedure arterial injury. NIS hospital type designation as
teaching versus non-teaching hospitals was used to evaluate
the providers’ market shares separately across the hospital
type in 1998 versus 2005.
Patient demographic characteristics compiled in the
NIS were used. We compared age, gender, race, insurance
payer type (Medicare, Medicaid, private insurance, or
other), and income bracket across the practitioner’s pa-
tients. Race was categorized by the following groups:
white, black, Hispanic, or other (Asians, Pacific Islanders,
and Native Americans). Race was missing in 6% of cases in
this cohort. Using the corresponding median household
income from the respective residential zip code, different
income brackets were created. The type of admission des-
ignated as elective, urgent, or emergent was compared
among the providers’ patients. The Elixhauser co-morbidity
software designed for use with administrative datasets was
utilized to identify patient co-morbidities for the purposes
of univariate and multivariate analyses.16
SAS 8.02 software (SAS Institute, Cary, NC) was used
to analyze data. The Shapiro-Wilks test was used to evaluate
continuous variables for normality. A Student’s t test was
used to determine statistical significance for continuous
s nep
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significance was defined as P  .05. Continuous variables
are presented as median and range. Univariate predictor
variables with a P  .10 were included in the multivariate
analysis. A Hosmer-Lemeshow goodness-of-fit test con-
firmed the model. Logistical regression data were tabulated
as odds ratios and 95% confidence interval (CI).
RESULTS
During the calendar years 1998-2005, and using the
restrictions outlined in the Methods, we identified 23,825
discharges that were used in this analysis. Using the algo-
rithm outlined, single specialty was identified in 83% of
these providers. Vascular surgeons were the largest provider
group (30.8%), followed by IC (28.4%) and IR (17%). The
specialty of 23.8% of the providers could not be categorized
specifically. These groups were not included in the analysis
of outcome, and comparisons were performed among pa-
tient groups whose provider specialty was identified. Table
III contains overall demographic data for patients in this
analysis. The majority of the patients overall were white
(70%) and male. Race data were missing in 6% of all cases
but among the data where a race was recorded, a signifi-
cantly higher portion of African-Americans were identified
among the vascular surgery group (16% vs IC 7.6% and IR
10.8%; P  .001). Hispanic patients were more highly
represented among the IC group.
The majority of the peripheral arterial interventions
were performed at teaching hospitals (52.3%). Comparing
the patients across the providers’ groups, it was noted that
the majority of the VS patients were treated at teaching
hospitals (58.6%), compared with the other specialty pa-
tients, who were less commonly treated at teaching hospi-
tals (46.5% IC and 48.4% IR; P  .001). The majority of
the procedures were classified as elective, but the IR group
had the highest rate of emergency procedures (29.2% com-
pared with VS 19.3% and IC 9.0%; P  .001) An elective
classification was highest among the IC group (69.3% vs
62.5% VS and 49.1% IR; P  .001). Renal failure was
highest among IR group (9.5% vs 8.2% VS and 5.2% IC)
and coronary artery disease was highest among the IC
patients (59.3% vs 38.3% VS and 34.6% IR). We found no
trend or significant changes in the comorbidities among the
specialty group patients through the study period. The
Table II. Index procedures used to identify practitioner s
VS IC
38.12 CEA
38.34 and 38.44 Open AAA
39.29 Peripheral bypass
39.71 EVAR
84.17, 84.15 Amp
00.66 PTCA
36.05-07 Coronary stent
37.21-23 Right, left and combined
AAA, Abdominal aortic aneurysm; Amp, amputation; CEA, carotid en
cardiologist; IR, interventional radiologist; perc. Nephrostomy, percutaneou
transjugular intrahepatic portosystemic shunt; VS, vascular surgeon.most common insurance payer was Medicare, but the ICgroup had the highest rate of privately insured and the VS
group had the highest rate of Medicaid recipients.
Market share. From 1998 to 2005, vascular surgeons
had the highest overall market share of peripheral interven-
tions in our study. VS market share of 30.8% was closely
followed by the IC market share (Fig 1A). The trend (Fig
1B) shows a decrease for the IR market share (33% in 1998
to 5.6% in 2005). During the study period, the VS market
share increased sharply from 27% in 1998 to 43% to 2005.
The ICs had the greatest proportional increase of the three
specialties. In our analysis, IC market share increased by
Table III. Characteristics of patients in this study by
specialty group
VS group IC group IR group
Age (yr)
Mean (Median) 69.7 (71) 68.6 (70) 67.2 (69)
Gender (%)
Male 53.2 55.6* 54.1
Female 46.8 44.4 45.9
Race (%)
White 75.6 77.6 80.9
Black 16.0* 7.6 10.8
Hispanic 5.4 9.8 6.3
Other 3.1 4.9 2.0
Primary insurance (%)
Medicare 69.7 68.7 69.2
Medicaid 4.5 3.5 4.3
Private 23.4 25.0* 22.5
Other 2.3 2.8 4.0
Highest income bracket (%) 27.3 26.5 28.0
Hospital type (%)
Teaching 58.6* 46.5 48.4
Non-teaching 42.8 54.5* 51.2
Admission type (%)
Elective 62.5 69.3* 49.1
Urgent 18.2 21.8 21.8
Emergent 19.3 9.0 29.2
Comorbidities (%)
Renal failure 8.2 5.2 9.5*
CAD 38.3 59.3* 34.6
Hypertension 64.4 63.3 56.5
Diabetes mellitus 27.5* 26.5 23.5
Complicated DM 11.3 6.2 13.3*
CAD, Coronary arterial disease; DM, diabetes mellitus.
*Indicates statistical significance (P  .05) across the rows as a result of
univariate analysis among the specialties.
lty
IR Other
catheterization
39.1 TIPS
55.03-04 Perc. nephrostomy
Overlap observed
ctomy; EVAR, endovascular aortic aneurysm repair; IC, interventional
hrostomy; PTCA, percutaneous transluminal coronary angioplasty; TIPS,pecia
heart
dartere2.8-fold from 10% in 1998 to 28% by 2005. Of note, yearly
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stable, ranging from 21% to 32%, with a median value of
22%.
Market share for the specialties at teaching versus non-
teaching hospitals was also compared at two data points,
years 1998 and 2005, depicted in Fig 2. At teaching hos-
pitals, the IRmarket share decreased by 7 fold (36% in 1998
to 5% in 2005; P  .001) whereas both the other two
specialties showed a significant and robust increase in their
market share at teaching institutions; VS (18% in 1998, 48%
in 2005; P .001) and IC (12% in 1998, 32% in 2005; P
.001). At non-teaching hospitals, although the VS market
share was higher in both 1998 and 2005, their market share
decreased (40% in 1998 to 35% in 2005), whereas the IC
market share showed a robust increase (8% in 1998 to 25%
in 2005; P .05). This three-fold increase in the ICmarket
share was matched by an almost three-fold decrease in the
IR market share (29% in 1998 to 8.5% in 2005; P  .05).
Univariate analysis of postoperative morbidity and
iatrogenic arterial injury. Overall the in-hospital crude
mortality rate was 1.3%. Univariate analysis for mortality
Fig 1. Overall (A) and trend (B) of specialties mark
1998-2005.
Fig 2. Comparison of market share among the specialties at dif-
ferent hospital types in 1998 versus 2005.showed that mortality was highest for women over 70 yearsof age. The mortality rate was significantly higher for
patients with renal failure, diabetes, and coronary artery
disease (Table IV). In-hospital mortality was highest for the
IR group (2.1% vs 1.2% VS and 0.6% IC; P  .05) (Fig 3).
Overall, in-hospital iatrogenic arterial injuries were re-
ported in 0.6% of cases. Factors affecting iatrogenic arterial
injury are summarized in Table V. Female patients had a
significantly higher rate of iatrogenic arterial injuries. Older
patients and those with CAD and DM had higher rates of
iatrogenic arterial injuries, but these did not achieve statis-
are performing peripheral arterial interventions from
Table IV. Univariate analysis for mortality rates: overall
mortality for patients in this analysis
Factor Rate P value
Age .0001
70 0.7%
70 1.7%
Gender .0001
Male 0.9%
Female 1.6%
Primary insurance .0001
Medicare 1.5%
Medicaid 1.4%
Private 0.5%
Other 0.7%
Admission type .0001
Elective 0.6%
Urgent 1.5%
Emergent 3.2%
Specific comorbidities
Renal failure 4.5% (1.0%) .0001
PVD 1.3% (1.1%) .14
DM 1.4% (0.9%) .008
DM, complicate 1.2% (2.0%) .0004
CAD 1.6% (0.9%) .0001
CAD, Coronary arterial disease; DM, diabetes mellitus; PVD, peripheral
vascular disease.
For specific comorbidities, parentheses are the mortality rate in patients
without those specific comorbidities (P values .05 are considered signifi-
cant).et shtical significance. A similar observation was noted for ur-
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rate, depicted in Fig 3, was highest for IC patients (2.4% vs
0.5% VS and 0.9% IR; P  .001). Hospital type did not
affect either mortality rates or iatrogenic post-procedure
arterial injury rates.
Multivariate analysis of in-hospital mortality and
iatrogenic arterial injury. The provider’s specialty was
independently associated with increased in-hospital mortal-
ity (Table VI). Compared with VS, IR patients had an
increased odds ratio for mortality (OR 1.62; 95% CI;
1.16-2.24) after adjustment for multiple covariates, includ-
Fig 3. Mortality and iatrogenic arterial injuries among the three
specialties. IR had the lowest mortality rate among the three
groups and IAI was lowest among VS groups. (*P  .05) IAI,
iatrogenic arterial injuries; IR, interventional radiologist; VS, vas-
cular surgeon.
Table V. Univariate analysis for iatrogenic arterial injury
rates
Factor Rate P value
Age .097
70 0.94%
70 0.74%
Gender .018
Male 0.71%
Female 0.99%
Primary insurance .42
Medicare 0.82%
Medicaid 1.07%
Private 0.79%
Other 1.33%
Admission type .32
Elective 0.65%
Urgent 0.92%
Emergent 0.86%
Specific comorbidities
Renal failure 0.40% (0.87%) .037
PVD 0.94% (0.77%) .17
DM 0.73% (0.88%) .288
DM, complicated 0.53% (0.87%) .085
CAD 0.88% (0.81%) .57
CAD, Coronary arterial disease; DM, diabetes mellitus; PVD, peripheral
vascular disease.
For specific comorbidities, parentheses are the mortality rate in patients
without those specific comorbidities.ing symptom type as well as co-morbid medical conditions.Similar analysis, comparing IC with VS, did not show an
increased odds of mortality for IC operators (OR 0.85; 95%
CI; 0.57-1.26). Other factors that were independently
predictive of in-hospital mortality were renal failure (OR
6.88; 95% CI 4.94-9.59), age (OR 1.06; 95% CI; 1.04-
1.07), female gender (1.51; 95% CI; 1.17-1.96), and type
of admission compared with elective admission. Hospital
type did not independently affect the mortality odds. Other
than renal failure, the other comorbidities did not adversely
affect mortality rates. Race also did not affect mortality.
By multivariate logistic regression, the operator type
was independently predictive of postoperative iatrogenic
arterial injury (Table VII). Compared with VS, both IC
operator and IR had an increased odds ratio for iatrogenic
arterial injury. Another independent factor for iatrogenic ar-
terial injurywas female gender (OR1.44; 95%CI; 1.07-1.92).
Age did not independently increase the odds ratio for post-
procedure iatrogenic injuries.
DISCUSSION
In this retrospective observational study of the most
recently available national data (1998-2005), we have
found that the VS and IC market shares for the ever-
increasing number of peripheral interventions have signifi-
cantly increased; VS from 27% 1998 to 43% in 2005 (P 
.001). During the same period, the IR market share has
Table VI. Multivariate analysis of in-hospital mortality
Factor Odds ratio 95% CI P value
Age 1.06 1.4-1.07 .001
Primary insurance vs
Medicare
Medicaid 0.61 0.84-3.09 .16
Private 0.74 0.42-2.66 20
Admission type vs
elective
Urgent 2.16 1.54-3.03 .001
Emergent 3.99 2.95-5.40 .001
Comorbidites
Renal failure 6.88 4.94-9.59 .001
Operator type vs VS
IC 0.85 0.57-1.26 .41
IR 1.62 1.16-2.24 .001
CI, Confidence interval; IC, interventional cardiologist; IR, interventional
radiologist; VS, vascular surgeon.
Table VII. Multivariate analysis of in-hospital iatrogenic
arterial injury
Factor Odds ratio 95% CI P value
Age 0.99 .98-1.01 .275
Female gender 1.44 1.07-1.92 .015
Operator type vs VS
IC 2.44 1.63-3.66 .0001
IR 1.75 1.08-2.81 .023
IC, Interventional cardiologist; IR, interventional radiologist; VS, vascular
surgeon.significantly decreased (33% in 1998 to 6% in 2005; P 
JOURNAL OF VASCULAR SURGERY
November 20091076 Eslami et al.001). Interventional cardiologists perform more than 30%
of in-hospital peripheral interventions. At teaching hospi-
tals, the VS market share has shown a more robust rise
during the study period (18% in 1998 to 48% in 2005, P
.001), mirroring a similar decline for the IR market share at
teaching hospitals (36% to 5%, P  .001). Vascular sur-
geons had the lowest combined overall post-procedure
iatrogenic arterial injury and mortality among the special-
ties (1.7% overall rate, IC 3.04%, and IR 3.00%; P .001).
By multivariate analysis adjusting for confounding vari-
ables, age, gender, and multiple co-morbid medical condi-
tions, patients who underwent peripheral interventions by
IR had higher odds of postoperative iatrogenic arterial
injuries (1.75) and in-hospital mortality than those in the
VS group. Interventional cardiologist operator was associ-
ated with a 2.4 times higher odds of post-procedure iatro-
genic arterial injury compared with VS operator.
Although the specific or precise guidelines for periph-
eral arterial interventions in patients with peripheral vascu-
lar disease are being defined, the number of peripheral
interventions is increasing at a rapid rate.9 Factors contrib-
uting to this rise in the number of interventions are varied
and may stem from higher rate of diagnosis of PAD by
primary care providers, an increasing US population age
with correspondingly higher arterial occlusive disease
rates,10 and the improvement of peripheral intervention
techniques that have expanded the role of these interven-
tions. But perhaps the most significant contributing factor
to an increasing number of peripheral interventions is ra-
diographic diagnosis when these patients undergo coronary
evaluations. It is well known that patients with coronary
artery disease often have peripheral arterial disease.11
Therefore, interventional cardiologists are often in a posi-
tion to diagnose angiographically peripheral occlusive dis-
ease. In a Medicare study, ICs performed 26% of all periph-
eral angioplasties.12 Interestingly, 25% of the peripheral
interventions were performed by ICs were within a month
after the coronary catheterization by the same IC who
performed the initial cardiac intervention.12 In our study,
we similarly found that ICs performed 28.4% of all the
cases. As the NIS database does not allow for longitudinal
follow-up of a particular patient, we cannot show a similar
relationship. Our study does, however, show that IC had
the highest rates of elective admissions for these interven-
tions, suggesting a prior diagnostic evaluation during car-
diac catheterization.
Another factor in increasing peripheral intervention
may be the acceptance of these procedures by currently
trained vascular surgeons who have extensive training in
endovascular techniques. In 2002, Kashyap et al published
a survey indicating that 50% of recently trained vascular
surgeons have adequate endovascular surgery training.17
Schanzer and colleagues showed a significant rise in the
volume of cases by recent vascular fellowship graduates,
mainly driven by endovascular cases.18 Endovascularly-
trained vascular surgeons feel comfortable with these inter-
ventions andmay offer these interventions more readily and
even instead of some of the traditional therapies. The bestexample is adoption of EVAR that is quickly replacing open
abdominal aortic aneurysm (AAA) repair.4,19 The substan-
tial increase in the market shares of vascular surgeons at the
teaching hospitals observed here is another example of
rapid adoption of endovascular techniques at these institu-
tions. The rapid adaptation of peripheral interventions at
these institutions may be a direct cause for the precipitous
drop in the IR market share at the teaching hospitals. Even
in institutions where IR and VS have formed a financial
entity, and despite an increase in overall number of inter-
ventional procedures, the VS market share increase has
outpaced that of IR.20 This may significantly affect the IR
training programs that are often at the same teaching
hospitals and may over time reshape that specialty.
The study shows a discrepancy in mortality and mor-
bidity between the practitioner types that was operator-
dependent. Interventional cardiologists had an overall rate
of 1.3% for iatrogenic arterial injuries. While causality can-
not be proven in administrative datasets, we propose that
one possible explanation for this is the possible use of larger
sheath by IC compared with the other specialties. Heintzen
et al, evaluating the outcome after more than 27,000
cardiac catheterizations, noted that the most important risk
factors for arterial injury were age, gender, and sheath size
used during interventions.21 This, however, may not be a
valid argument, as most peripheral interventions are often
performed using 6F sheaths, and this sheath is the most
commonly used in cardiac catheterization. Perhaps a better
explanation may be explained by the findings noted previ-
ously by Axelrod.12 The authors noted that 25% of periph-
eral interventions performed by cardiologists are performed
“soon after” cardiac catheterization.12 Only 5% of periph-
eral interventions were performed the same day as cardiac
catheterization.12 In our study, we also noted that the IC
group had a significantly higher rate of elective admission
among the operators, perhaps indicating a recent cardiac
catheterization where a peripheral lesion was also identi-
fied. Re-entry of the access artery within a short time after
the initial cardiac catheterization may predispose these
arteries to injury and may lead to a higher rate of arterial
injury among IC patients. Additionally, it has been esti-
mated that more than 50% of cardiac catheterizations em-
ploy some sort of arterial closure device.22 Although the
safety and efficacy of these devices are debated,22,23 we
speculate that these risks may be compounded particularly
if the same artery is accessed within a short interval. One
other consideration for safety of peripheral intervention is
whether angioplasty and stenting or angioplasty alone was
performed. We could not clearly delineate any practice
patterns across the specialties.
The limitations of studies based on administrative data-
sets such as the NIS have been described previously.24
Coding inaccuracies in terms of patient case-mix, such as
prevalence of co-morbidities, or complications such as
postoperative arterial injury, are possible. To minimize
these inaccuracies, we used established co-morbidity soft-
ware to attempt to appropriately characterize patients with
pre-existing co-morbid conditions.16 Likewise, to identify
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ICD9-CM code. Additionally, in-hospital outcomes are a
suboptimal measure of overall success when evaluating surgi-
cal interventions. Ideally, long-term information such as
30-day and one-year arterial injury and mortality rates
provide a better measure of post-procedure mortality and
stroke among the specialties. However due to the arduous
patient de-identification process employed by the NIS, fol-
low-up information is unavailable.
Specific to this study, the most critical criticism is
perhaps the lack of information for outpatient procedures
that may redefine market share. The NIS database is exclu-
sively for inpatient procedures, and therefore the market
share for outpatient procedures cannot be estimated. An
unknown portion of these procedures that were performed
on an outpatient basis is therefore missing from this data-
base, and that may change the market share trends. None-
theless, others using different methodologies and databases
have shown a similar trend of declining IR market share at
the time of rising IC and VSmarket shares,25 and our values
are similar to those reported by Axelrod.12 Additionally,
the current practice patterns must be placed in the appro-
priate historical perspectives. Admittedly, a large number of
these procedures are performed in the outpatient setting.
But even in 2003, the recommendations of the Society of
Interventional Radiology Standards of Practice Guidelines
called for in-hospital observation.26 The concept of safety
and efficacy of outpatient peripheral angioplasty is more
recent.27 We therefore believe that the in-hospital dis-
charges recorded in the NIS accurately record the majority
of the patients who underwent peripheral angioplasty in the
period analyzed. Lastly, using the algorithm noted, we
could not identify 23.8% of the providers’ specialties. As
this group’s contribution to the market share was stable
across the study period without any discernable pattern, it is
apparent that this group’s contribution does not affect the
conclusions about the market share trend. This can be
explained thus: if we divide the practitioners as VS and
non-VS that included all the other specialties, the market
share for VS increased from about 27% to 43%, while others
decreased from 75% in 1998 to 57%. Similar analyses for the
market share trends for IR and IC specialties yield results
similar to those previously enumerated. In other words, as
the contribution of the “other/missing” group is stable, its
relative effect to the market share trend discussion is negli-
gible and does not affect the overall market trends.
One other point must be made here. The study period
in this analysis is very similar to previous publication by
Nowygrod et al.9 These authors have used the similar
database and similar method (use of ICD-9 CM codes),
and the numbers of peripheral interventions reported there
are significantly higher than that reported here. The reason
is that we did not use weighing strategies to arrive at an
estimated number of cases and we used the actual number
of cases. Additionally, as we were set to evaluate the
trends across the providers, we only included discharges
catalogued by NIS that included a provider identifier for
the index admission. A combination of these two factorsare the main reason that the number of discharges ana-
lyzed here (23,825) are significantly less than those
included in the Nowygrod et al study.9
In conclusion, we observe that the VS and IC market
shares are increasing while the IR market share is decreas-
ing. Vascular surgeons have the lowest overall mortality and
morbidity of all providers, indicating that the endovascu-
larly trained vascular surgeons will continue to increase
their market share given their safety records. Vascular sur-
geons should actively promote and increase the number of
endovascular training programs to increase their market
share in peripheral interventions.
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The authors examine market share trends and outcomes for
vascular surgeons (VS), interventional radiologists (IR), and inter-
ventional cardiologists (IC) performing peripheral arterial inter-
ventions (PAI) during 1998-2005, utilizing retrospective data
from the National Inpatient Sample. Their conclusions that VS
(and IC) volumes have increased significantly along with the
lowest mortality and morbidity using iatrogenic injuries as a
marker will warm the hearts of current and future VS. However, it
must be remembered that the 23,825 cases represent a very small
sample of inpatients and approximately 3% of all interventions
performed annually in the U.S. In addition, almost 25% of inter-
ventionist specialties could not be discerned, intra-arterial injury
was used as the sole marker for morbidity, and interventionist
specialties were deduced indirectly through an algorithm based on
the type of procedures performed.
Nevertheless, the tantalizing and encouraging conclusions
should cause us to study trends in overall market share for periph-
eral interventions and focus on the common quality measures most
departments and hospitals utilize to issue ‘report’ cards. The
American Recovery and Reinvestment Act of 2009 (ARRA) calls
for a vague mandate for ‘comparative effectiveness research.’ Whatthough the Pay for Performance (P4P) program initiated byMedi-
care and followed by private insurers has not caught on as much as
was expected due to the dwarfian incentives, the Physician Quality
Reporting Initiative (PQRI) measures will probably be expanded.
The authors also noted that IC had the highest rates of elective
admissions for peripheral interventions, suggesting, as others have,
that some IC ‘find’ these lesions during cardiac catheterizations.
VS are heavily outnumbered by sheer numbers of IC and yet I
suspect that the increased market share for VS has resulted from an
aggressive approach by our specialty in teaching its members and
trainees the skill sets needed to achieve superior results.
Total transparency of results and quality indicators made
public in a proactive manner is critical to prevent insurance or
governmental efforts to impose their own ill-defined standards.
The specialty that acts in a coordinated and proactive manner to
demonstrate the quality of work (tied to low mortality and com-
plication rates and hence lower costs) performed by its members
will eventually be the dominant specialty. A combination of first-
rate training of the complete specialist (open/closed procedures),
demonstration of superior results by hard data, and occasionally
tooting our own horn should stand the future generation of VS in
good stead.
